Dynavax Gmbh company information, Employees & Contact Information

Dynavax (Nasdaq: DVAX) sets Nov. 5 results call at 4:30 p.m. ET; webcast replay available Stock Titan

Dynavax to Participate in the 2025 Wells Fargo Healthcare Conference PR Newswire

Dynavax Technologies’ Investigational Shingles Vaccine Achieves Complete Antibody Response in Phase I/II Shingles Trial Applied Clinical Trials

Dynavax’s shingles vaccine shows promise in trial against GSK’s Shingrix Clinical Trials Arena

Dynavax Technologies Corporation (DVAX) Reports Record $92M HEPLISAV-B Revenue, Raises 2025 Outlook Yahoo Finance

Dynavax's shingles vaccine shows similar immune response to GSK's shot in study Reuters

Published on: 2025-10-19 02:39:01 Trung tâm Dự báo KTTV quốc gia

Dynavax Technologies Stock (DVAX) Opinions on Shingles Vaccine Trial Results | DVAX Stock News Quiver Quantitative

Dynavax Technologies: A Dip To Accumulate (NASDAQ:DVAX) Seeking Alpha

Dynavax's feud with activist investor heats up ahead of annual meeting Fierce Biotech

Dynavax (NASDAQ: DVAX) starts Part 2 for Z-1018, enrolling approximately 324 vs Shingrix Stock Titan

Dynavax Comments on Glass Lewis Recommendation PR Newswire

Dynavax Announces Positive Topline Phase 1/2 Results Supporting Potential Best-in-Class Shingles Vaccine Profile Yahoo Finance

Dynavax Technologies: Hepatitis-B Vaccine Specialist Looking Good (NASDAQ:DVAX) Seeking Alpha

Investor Deep Track launches proxy fight at Dynavax, nominates 4 directors Reuters

VC firm launches proxy fight to end Dynavax's 'empire-building' Fierce Biotech

Dynavax Technologies: A Post-Earnings Assessment With Growing Market Share Seeking Alpha

Dynavax Earnings: Vaccine Maker to Report Q2 Results as HEPLISAV-B Sales Growth Continues Stock Titan

Vaccine Developer Dynavax to Showcase HEPLISAV-B and COVID-19 Programs at Wells Fargo Conference Stock Titan

Dynavax drops Tdap vaccine after considering phase 1 data, competition Fierce Biotech

Dynavax Responds to Deep Track and Highlights Long-Term Value Creation Strategy PR Newswire

Dynavax Adopts Limited-Duration Stockholder Rights Plan PR Newswire

CEPI and Dynavax expand collaboration to increase supply of adjuvant for COVID-19 vaccines CEPI

Dynavax Announces $100 Million Accelerated Share Repurchase Program PR Newswire

Dynavax touts shingles vaccine's efficacy as 'comparable' to Shingrix FirstWord Pharma

Citizens JMP Reiterates a Buy Rating on Dynavax Technologies (DVAX) With a Price Target of $31 Yahoo Finance

Glass Lewis backs two of Deep Track's four nominees in Dynavax fight Reuters

Dynavax (DVAX) Q2 Revenue Jumps 29% Nasdaq

Dynavax-sponsored survey shows lack of awareness of hepatitis B risks, vaccine options Fierce Pharma

Dynavax has GSK's shingles vaccine in its sights pharmaphorum

Dynavax Technologies Corporation Reported A Surprise Loss, And Analysts Have Updated Their Forecasts simplywall.st

Dynavax stock soars after positive shingles vaccine trial results Investing.com

Dynavax eyes up Shingrix’s multi-billion monopoly The Pharma Letter

Vaccine maker Dynavax's future hangs in balance amid activist investor showdown The Business Journals

Dynavax shareholders reject activist's director slate The Business Journals

Dynavax says shingles shot performed on par with GSK’s Shingrix in Phase 1/2 trial Seeking Alpha

US FDA declines expanded use of Dynavax's hepatitis B vaccine on insufficient data Reuters

Dynavax's Evolving Business Model Life Science Leader

Despite Hepatitis B Apathy, Dynavax Delivers Strong Vaccine Revenue 05/08/2025 MediaPost

Dynavax’s Experimental Shingles Vaccine Shows Positive Results In Study: Retail Expects Stock Rally To Continue Into Friday Stocktwits

With ACIP recommendation, is tiny Dynavax set to win the hepatitis B sweepstakes with Heplisav-B? Fierce Pharma

Dynavax continues to shed staffers as CSO to leave with no replacement plan Fierce Biotech

Dynavax axes immuno-oncology pipeline and 82 staff Fierce Biotech

Why Dynavax Technologies Stock Is Sliding Today The Motley Fool

Dynavax Signs a Pact to Develop Universal Influenza Vaccine Yahoo Finance

Is the new Dynavax hepatitis vaccine safe? I couldn’t tell — and I was advising the FDA statnews.com

Why Dynavax, Novavax, and Sorrento Soared This Week The Motley Fool

Is Dynavax Technologies Corporation a Buy? The Motley Fool

Persistence pays off for Dynavax as twice-rejected hepatitis B vaccine wins FDA nod Fierce Pharma

Dynavax Technologies (DVAX) Zacks Investment Research